Australia’s Therapeutic Goods Administration will reclassify all codeine products to ‘prescription only’ from February 1, in a bid to combat opioid tolerance, dependence and poisoning.
Sanofi-Aventis is to sell its liquid drug manufacturing plant in Colomiers, southwest France, to industry specialist Unither for an as yet undisclosed sum.
Several big drug-makers are voluntarily recalling some of their
cough and cold products for under-two-year-olds in the US as a
precautionary measure against overdosing on the drugs.